Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

Also called NCT07795593

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07795593
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07795593. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2031-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
Acronym
MCPAIN
Condition
Painful Diabetic Neuropathy (PDN)
Condition
Diabetic Nephropathies
Intervention (Device)
Cognitive Behavioral Therapy (CBT)
Intervention (Drug)
Oral Medication
Intervention (Drug)
Topical Medication
Lead sponsor
University of Michigan (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)

Record details

Record id
cardio:ct-nct07795593
Content hash
c5816f7298f099d65f81b0178a0dc25a06a0f962196c06470a195c1c3208bf65